This content is protected against AI scraping.
Cannabis DUI laws are still relying on a number that doesn’t actually tell us whether someone is too high to drive. Unlike alcohol, THC levels in the bloodstream don’t reliably correspond to impairment, particularly for regular cannabis users. A 2025 UC San Diego study found that nearly one in four regular users still had measurable THC levels after 48 hours without consuming cannabis, despite showing no difference in simulated driving ability. Meanwhile, roadside sobriety tests aren’t much better: nearly half of participants who had smoked a placebo (and weren’t actually high) were incorrectly judged impaired by trained officers.
The bigger problem is that cannabis users often face stricter DUI standards than people taking certain prescription medications, even when those medications carry a greater documented risk of crashes. In 18 states, drivers can be penalized simply for having detectable THC in their system, regardless of whether they’re impaired. That can put medical cannabis patients at a disadvantage, since THC can remain in their blood long after its effects have worn off. Researchers estimate that cannabis-related impairment can last anywhere from three to ten hours, depending on dosage, consumption method and individual tolerance.
The science is getting clearer, but the laws haven’t caught up. A THC blood test can’t reliably distinguish an impaired driver from a sober daily user, and current roadside tests can produce plenty of false positives. Until lawmakers establish more reliable, impairment-based standards, medical cannabis patients will continue to face legal consequences that don’t necessarily reflect whether they were actually safe to drive.
This is a summary.
Please read the original article: A Driver on Prescribed Xanax Must Be Proven Impaired. For Cannabis Patients, a THC Blood Test Can Be Enough.
Original article written by Rolando García. Published on November 15, 2026 by HighTimes.







